Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma Co N.V (NAMS) Return on Assets: 2024-2025

Historic Return on Assets for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to -0.28%.

  • NewAmsterdam Pharma Co N.V's Return on Assets rose 17.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.40% for FY2024, which is 62.00% up from last year.
  • Latest data reveals that NewAmsterdam Pharma Co N.V reported Return on Assets of -0.28% as of Q3 2025, which was down 36.07% from -0.20% recorded in Q2 2025.
  • NewAmsterdam Pharma Co N.V's 5-year Return on Assets high stood at -0.20% for Q2 2025, and its period low was -0.55% during Q1 2024.
  • Its 2-year average for Return on Assets is -0.37%, with a median of -0.37% in 2024.
  • Data for NewAmsterdam Pharma Co N.V's Return on Assets shows a peak YoY surged of 32bps (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows NewAmsterdam Pharma Co N.V's Return on Assets stood at -0.37% in 2024, then increased by 17bps to -0.28% in 2025.
  • Its Return on Assets stands at -0.28% for Q3 2025, versus -0.20% for Q2 2025 and -0.22% for Q1 2025.